Immunohistochemical expression of E-cadherin does not distinguish canine cutaneous histiocytoma from other canine round cell tumors

Veterinary Pathology

Volumn 48, Issue 3, 2011, Pages 758-763

  Ramos Vara, José A ^a   Miller, M A ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

canine cutaneous histiocytoma; epitheliotropic lymphoma; immunohistochemistry; leukocytes; mast cell tumor; plasmacytoma; round cell tumor

Indexed keywords

CADHERIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; DERMATOFIBROMA; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; GENE EXPRESSION REGULATION; GENETICS; HISTIOCYTIC SARCOMA; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MASTOCYTOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLASMACYTOMA;

ANIMALS; CADHERINS; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTIOCYTIC SARCOMA; HISTIOCYTOMA, BENIGN FIBROUS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MASTOCYTOMA; PLASMACYTOMA;

EID: 79955796971     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985811398251     Document Type: Article

References (36)

1. Aiba S,Nakagawa S,Ozawa H,Tagami H. Different expression of E-cadherin by two cutaneous gamma/delta TcR+ T-cell subsets, V gamma 5- and V gamma 5+ gamma/delta TcR+ T Cells.J Invest Dermatol. 1995;105: 379-382.
2. Armenau S,Bühring H-J,Reuss-Borst M,Müller CA,Klein G. E-cadherin is functionally involved in the maturation of the erythroid lineage.J Cell Biol. 1995;131: 243-249.
3. Ashton-Key M,Cowley GP,Smith MEF. Cadherins in reactive lymph nodes and lymphomas: high expression in anaplastic large cell lymphomas.Histopathology. 1996;28: 55-59.
4. Baines SJ,McInnes EF,McConnell I. E-cadherin expression in canine cutaneous histiocytomas.Vet Rec. 2008;162: 509-513.
5. Boyer B,Dufour S,Thiery JO. E-cadherin expression during the acidic FGF-induced dispersion of a rat bladder carcinoma cell line.Exp Cell Res. 1992;201: 347-357.
6. Chetty R,Serra S. Nuclear E-cadherin immunoexpression: from biology to potential implications in diagnostic pathology.Adv Anat Pathol. 2008;15: 234-240.
7. Chetty R,Serra S,Asa SL. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.Am J Surg Pathol. 2008;32: 413-419.
8. Chim C-S,Liang R,Leung M-H,Kwong Y-L. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma.J Clin Path. 2007;60: 104-106.
9. Florian S,Sonneck K,Czerny M,Hennersdorf F,Hauswirth AW,Bühring H-J,Valent P. Detection of novel leukocyte differentiation antigens on basophils and mast cells by HLDA8 antibodies.Allergy. 2006;61: 1054-1062.
10. Gil da Costa RM,Rema A,Pires MA,Gärtner F. Two canine Merkel cell tumors: immunoexpression of c-KIT, E-cadherin, β-catenin and S100 protein.Vet Dermatol. 2010;21: 198-201.
11. Horiguchi Y,Furukawa F,Fujita M,Imamura S. Ultrastructural localization of E-cadherin cell adhesion molecule on the cytoplasmic membrane of keratinocytes in vivo and in vitro.J Histochem Cytochem. 1994;42: 1333-1340.
12. Jakob T,Brown MJ,Udey MC. Characterization of E-cadherin-containing junctions involving skin-derived dendritic cells.J Invest Dermatol. 1999;112: 102-108.
13. Liangzhe W,Huimin L,Jin H,Yuli L,Yi X,Bing C. E-cadherin expression and its clinical significance in 41 cases of spinal plasma cell myeloma.J Med Colleges PLA. 2009;24: 56-62.
14. Melki JR,Vincent PC,Brown RD,Clark SJ. Hypermethylation of E-cadherin in leukemia.Blood. 2000;95: 3208-3213.
15. Nishida M,Kawai K,Tanaka M,Tegoshi T,Arizono N. Expression of E-cadherin in human mast cell line HMC-1.APMIS. 2003;111: 1067-1074.
16. Patnaik AK,Ehler WJ,MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs.Vet Pathol. 1984;21: 469-474.
17. Pires I,Alves A,Rodrigues P,Queiroga FL. E-cadherin expression in canine cutaneous histiocytoma.Vet Rec. 2008;163: 59-60.
18. Pires I,Queiroga FL,Alves A,Silva F,Lopes C. Decrease of E-cadherin expression in canine cutaneous histiocytoma appears to be related to its spontaneous regression.Anticancer Res. 2009;29: 2713-2717.
19. Ramos-Vara JA. Technical aspects of immunohistochemistry.Vet Pathol. 2005;42: 405-426.
20. Ramos-Vara JA,Beissenherz ME. Optimization of immunohistochemical methods using two different antigen retrieval methods on formalin-fixed, paraffin-embedded tissues: experience with 63 markers.J Vet Diagn Invest. 2000;12: 307-311.
21. Ramos-Vara JA,Miller MA. Immunohistochemical detection of protein gene product 9.5 (PGP 9.5) in canine epitheliotropic T-cell lymphoma (mycosis fungoides).Vet Pathol. 2007;44: 74-79.
22. Ramos-Vara JA,Miller MA,Gilbreath E,Patterson JS. Immunohistochemical detection of CD34, E-cadherin, claudin-1, GLUT-1, laminin, and PGP 9.5 in 28 canine and 8 feline meningiomas.Vet Pathol. 2010;47: 725-737.
23. Ramos-Vara JA,Miller MA,Valli VEO. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.Vet Pathol. 2007;44: 875-884.
24. Rodriguez-Sastre MA,González-Maya L,Delgado R,Lizano M,Tsubaki G,Mohar A,García-Carrancá A. Abnormal distribution of E-cadherin and-catenin in different histologic types of cancer of the uterine cervix.Gynecol Oncol. 2005;97: 330-336.
25. Seidel S,Ackermann H,Kaufmann H,Keck A,Nösslinger T,Zielinski CC,Drach J,Zöchbauer-Müller S. DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies.Cancer. 2004;100: 2598-2606.
26. Shimoyama Y,Hirohashi S,Hirano S,Noguchi M,Shimosato Y,Takeichi M,Abe O. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas.Cancer Res. 1989;49: 2128-2133.
27. Suzuki A,Suzuki R,Furuno T,Teshima R,Nakanishi M. N-cadherin plays a role in the synapse-like structures between mast cells and neuritis.Biol Pharm Bull. 2004;27: 1891-1894.
28. Syrigos KN,Harrington KJ,Karayiannakis AJ,Baibas N,Katirtzoglou N,Roussou P. Circulating soluble E-cadherin levels are of prognostic significance in patients with multiple myeloma.Anticancer Res. 2004;24: 2027-2032.
29. Tegoshi T,Nishida M,Arizono N. Expression and role of E-cadherin and CD103β7 (αβ7 integrin) on cultured mucosal-type mast cells.APMIS. 113: 91-98.
30. Tegoshi T,Nishida M,Ishiwata K,Kobayashi T,Uchiyama F,Nabeshima K,Nawa Y,Arizono N. E-cadherin and cadherin-associated cytoplasmic proteins are expressed in murine mast cells.Lab Invest. 2000;80: 1571-1581.
31. Udey MC. Cadherins and Langerhans cell immunology.Clin Exp Immunol. 1997;107 (Suppl 1): 6-8.
32. Valli VE,Jacobs RM,Parodi AL,Vernau W,Moore PF 2nd ed. Washington, DC: Armed Forces Institute of Pathology; 2002:.
33. Vallorosi CJ,Dat CD,Zhao X,Rashid MG,Rubin MA,Johnson KR,Wheelock MJ,Day ML. Truncation of the β-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution.J Biol Chem. 2000;275: 3328-3334.
34. Wayner EA,Hoffstrom B,Pittlekow M. T lymphocyte adhesion by keratinocytes: cooperative role for the integrin receptor α3β1 and E-cadherin.J Invest Dermatol. 1994;102: 524.
35. Webster JD,Kiupel M,Kaneene JB,Miller R,Yuzbasiyan-Gurkan V. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.Vet Pathol. 2004;41: 371-377.
36. Yuregir OO,Yurtcu E,Kizilkilic E,Kocer E,Ozdogu H,Sahin FI. Detecting methylation patterns of p16, MGMT, DAPK, and E-cadherin genes in multiple myeloma patients.Internat J Lab Hematol. 2010;32: 142-149.